Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Clinical and Molecular Hepatology. 2017;23(3):239-248 
Lack of Alpha-fetoprotein reduction after successful Hepatitis C treatment in patients with cirrhosis predicts the development of hepatocellular carcinoma during surveillance-a single unit real-world experience
Journal of Hepatology. 2022;77:S569
Surveillance for Hepatocellular Carcinoma
Hepatocellular Carcinoma. 2016;339-354
Hepatocellular Carcinoma: Diagnosis and Surveillance
Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022;
Surveillance algorithm and diagnostic algorithm for hepatocellular carcinoma
Hepatology Research. 2010;40:6-7
Letter to the Editor: Hepatocellular Carcinoma Surveillance in Cirrhosis Patients: Is the Real‐World Situation Even Worse Than Reported?
Hepatology. 2021;74(3):1714-1715
Mo1453 – Surveillance of Hepatocellular Carcinoma (HCC) with Ultrasound (US): A Real World Experience
Gastroenterology. 2019;156(6):S-1312
960 Alpha-Fetoprotein Should Not Be Excluded As Part of Surveillance for Hepatocellular Carcinoma in the Real World Setting
Gastroenterology. 2013;144(5):S-968
In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
Annals of Hepatology. 2004;3(4):152-159
Tu2040 Preventive Surveillance in Patients That Develop Hepatocellular Carcinoma: How Are We Doing?
Gastroenterology. 2015;148(4):S-967